Thursday August 27, 2026 – 4pm – Auditoire 51G
Vladyslav SHAPOVAL – TFAR CLIP
Exploring barriers, strategies, and evaluation approaches for implementing benzodiazepine deprescribing in European older adults
Promotor: Prof. Anne Spinewine and Co-promotor: Prof. Séverine Henrard
Related publication:
• López-Toribio M et al. (submitted in June 2026). Process evaluation of the BE-SAFE cluster randomised controlled trial: a research protocol. BMJ Open. Under review
• Shapoval V et al. (2025). Barriers to discontinuing benzodiazepine receptor agonists in older adults: a survey of older adults across Europe. Age and Ageing. doi:10.1093/ageing/afaf342
• Shapoval V et al. (2025). Barriers to and enablers of supporting deprescribing benzodiazepines in older adults: a survey of European nonphysician healthcare professionals. Basic & Clinical Pharmacology & Toxicology. doi:10.1111/bcpt.70100
• Shapoval V et al. (2025). Barriers to deprescribing benzodiazepines in older adults in a survey of European physicians. JAMA Network Open. doi:10.1001/jamanetworkopen.2024.59883